elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide
ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE (elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide) by Apotex is fixed-dose combination of antiretroviral drugs elvitegravir (plus the cyp3a inhibitor cobicistat), emtricitabine, and tenofovir alafenamide [see ] .
Drug data last refreshed 13h ago
fixed-dose combination of antiretroviral drugs elvitegravir (plus the CYP3A inhibitor cobicistat), emtricitabine, and tenofovir alafenamide [see ] .
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE at Apotex? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.